LungLife AI, Inc. – LSE:LLAI.L

LungLife AI stock price today

GBP 144
+135.25
+1545.71%
Financial Health
0
1
2
3
4
5
6
7
8
9

LungLife AI stock price monthly change

-38.60%
month

LungLife AI stock price quarterly change

-38.60%
quarter

LungLife AI stock price yearly change

-79.89%
year

LungLife AI key metrics

Market Cap
2.26M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.21
Revenue
46K
EBITDA
-5.37M
Income
-5.41M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-11691.3%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

LungLife AI stock price history

LungLife AI stock forecast

LungLife AI financial statements

LungLife AI, Inc. (LSE:LLAI.L): Profit margin
Mar 2023 11.5K -1.40M -12204.35%
Jun 2023 11.5K -1.40M -12204.35%
Sep 2023 11.5K -1.30M -11330.43%
Dec 2023 11.5K -1.30M -11330.43%
LungLife AI, Inc. (LSE:LLAI.L): Analyst Estimates
2025 4.59M -1.70M -37.04%
2026 1.20M 690.88K 57.34%
  • Analysts Price target

  • Financials & Ratios estimates

LungLife AI, Inc. (LSE:LLAI.L): Debt to assets
Mar 2023 12121000 1.66M 13.76%
Jun 2023 12121000 1.66M 13.76%
Sep 2023 9522000 1.60M 16.9%
Dec 2023 9522000 1.60M 16.9%
LungLife AI, Inc. (LSE:LLAI.L): Cash Flow
Mar 2023 -1.35M 1.12M -22K
Jun 2023 -1.35M 1.12M -22K
Sep 2023 -1.16M 1.35M -126K
Dec 2023 -1.16M 1.35M -126K

LungLife AI alternative data

LungLife AI, Inc. (LSE:LLAI.L): Employee count
Aug 2023 14
Sep 2023 15
Oct 2023 15
Nov 2023 15
Dec 2023 15
Jan 2024 15
Feb 2024 15
Mar 2024 15
Apr 2024 15
May 2024 15
Jun 2024 15
Jul 2024 15

LungLife AI other data

  • What's the price of LungLife AI stock today?

    One share of LungLife AI stock can currently be purchased for approximately $144.

  • When is LungLife AI's next earnings date?

    Unfortunately, LungLife AI's (LLAI.L) next earnings date is currently unknown.

  • Does LungLife AI pay dividends?

    No, LungLife AI does not pay dividends.

  • How much money does LungLife AI make?

    LungLife AI has a market capitalization of 2.26M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 91.67% to 46K US dollars.

  • What is LungLife AI's stock symbol?

    LungLife AI, Inc. is traded on the LSE under the ticker symbol "LLAI.L".

  • What is LungLife AI's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of LungLife AI?

    Shares of LungLife AI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does LungLife AI have?

    As Jul 2024, LungLife AI employs 15 workers.

  • When LungLife AI went public?

    LungLife AI, Inc. is publicly traded company for more then 4 years since IPO on 8 Jul 2021.

  • What is LungLife AI's official website?

    The official website for LungLife AI is lunglifeai.com.

  • Where are LungLife AI's headquarters?

    LungLife AI is headquartered at 2545 West Hillcrest Drive, Thousand Oaks, CA.

  • How can i contact LungLife AI?

    LungLife AI's mailing address is 2545 West Hillcrest Drive, Thousand Oaks, CA and company can be reached via phone at 805-409-9868.

LungLife AI company profile:

LungLife AI, Inc.

lunglifeai.com
Exchange:

LSE

Full time employees:

8

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.

2545 West Hillcrest Drive
Thousand Oaks, CA 91320

:
ISIN: USU5500L1045
: